Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001869436 | SCV002146589 | pathogenic | not provided | 2022-07-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln36Lysfs*44) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CNGB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 812290). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005047186 | SCV005674426 | likely pathogenic | Achromatopsia 3 | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001002982 | SCV001161035 | pathogenic | Achromatopsia | 2019-06-23 | no assertion criteria provided | research |